Validation pour Ingenuity264

vers la météo de la validation par utilisateur

Ingenuity264

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 37 - PMID ?

In major pelvic ganglion from SP , NODE and deferoxamine mesylate and NODE protein and triethylene tetramine dihydrochloride decrease expression of SP NODE mRNA that is increased by experimentally induced diabetes of SP .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 1

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 2

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 3

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 4

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 5

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 6

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 7

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 8

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 9

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 10

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 11

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 12

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                         |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+                                         |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 13

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+                                                  |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 14

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          +------------------------------------------------COMP:N-N(of)------------------------------------------------+                                                             |    
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+                                                             |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                                             |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 15

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          +------------------------------------------------COMP:N-N(of)------------------------------------------------+                                                             |    
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+                                                             |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                                             |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 16

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         +-------------------------------------------------------------COMP:N-N(of)-------------------------------------------------------------+                                         |                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         +------------------------------------------------COMP:N-N(of)------------------------------------------------+                                         |                        
                                  |         |                         |                    +--------------------------------------COMP:N-N(of)-------------------------------------+                                         |                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                         |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+                                         |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,mRNA)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 17

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          +------------------------------------------------COMP:N-N(of)------------------------------------------------+                                         |                        
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+                                         |                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                         |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+                                         |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 18

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------+                        
                                  |         |                         |            +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                        
                                  |         |                         |            |       +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |            |       +--------------------------------------COMP:N-N(of)-------------------------------------+                                         |                        
                                  |         |                         |            |       |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                         |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+                                         |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,mesylate)
COMP:V-N(In) (induce,__NODE__)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 19

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          +------------------------------------------------COMP:N-N(of)------------------------------------------------+                                                             |    
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+                                                             |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                                             |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 20

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+                                                  |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 21

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          +------------------------------------------------COMP:N-N(of)------------------------------------------------+                                                             |    
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+                                                             |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                                             |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 22

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          +------------------------------------------------COMP:N-N(of)------------------------------------------------+                                                             |    
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+                                                             |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                                             |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 23

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                                             |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 24

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
      +--------------------MOD_ATT:N-ADJ-------------------+---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
      |      +----------------MOD_ATT:N-ADJ----------------+          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
      +------------MOD_ATT:N-ADJ------------+              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
      |      +---------MOD_ATT:N-ADJ--------+              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                         |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+                                         |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 25

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+                                                             |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                                             |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 26

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                                             |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 27

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                         |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+                                         |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 28

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
      +--------------------MOD_ATT:N-ADJ-------------------+          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
      |      +----------------MOD_ATT:N-ADJ----------------+          +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                                            |    
      +------------MOD_ATT:N-ADJ------------+              |          |                    +------------------------------COMP:N-N(of)------------------------------+                                                                            |    
      |      +---------MOD_ATT:N-ADJ--------+              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           +-------------------------OBJ:V-N------------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           |              +-----------------SUBJ:V-N----------------+                   |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,mRNA)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 29

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 30

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 31

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 32

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+                                                                            |    
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                                            |    
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+                                                                            |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           +-------------------------OBJ:V-N------------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |              +-----------------SUBJ:V-N----------------+                   |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,mRNA)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 33

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 34

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 35

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 36

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 37

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 38

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      |              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 39

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                                   
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 40

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                                   
                                  |         |              +-------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------+                                                   
                                  |         |              |          +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |              |          +------------------------------------------------COMP:N-N(of)------------------------------------------------+              |                                                   
                                  |         |              |          |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+              |                                                   
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(In) (increase,__NODE__)
COMP:V-N(In) (increase,deferoxamine)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 41

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           +-------------------------OBJ:V-N------------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           |              +-----------------SUBJ:V-N----------------+                   |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,mRNA)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 42

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      |              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 43

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                                   
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 44

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 45

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                                   
                                  |         |              +-------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------+                                                   
                                  |         |              |          +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |              |          |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(In) (increase,__NODE__)
COMP:V-N(In) (increase,deferoxamine)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 46

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 47

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+                                                   
                                  |         |                         +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |                         |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |                         |                    +--------------------------------------COMP:N-N(of)-------------------------------------+              |                                                   
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 48

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
      +--------------------MOD_ATT:N-ADJ-------------------+                                                                                  |                                                                                                       
      |      +----------------MOD_ATT:N-ADJ----------------+                                                                                  |                                                                                                       
      +------------MOD_ATT:N-ADJ------------+              +-----------------------------------COMP:V-N(In)-----------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      |      +---------MOD_ATT:N-ADJ--------+              |          +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 49

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 50

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+                                                                            |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           +-------------------------OBJ:V-N------------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |              +-----------------SUBJ:V-N----------------+                   |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,mRNA)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 51

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+                                                   
                                  |         |                         +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |                         |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 52

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                                            |    
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+                                                                            |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           +-------------------------OBJ:V-N------------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |              +-----------------SUBJ:V-N----------------+                   |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,mRNA)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 53

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   +---------------------OBJ:V-N--------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +-----------------SUBJ:V-N----------------+                   |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      |              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD:V_PASS-ADV (increase,by)
OBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mRNA)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 54

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           +-------------------------OBJ:V-N------------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           |              +-----------------SUBJ:V-N----------------+                   |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,mRNA)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 55

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
      +--------------------MOD_ATT:N-ADJ-------------------+          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
      |      +----------------MOD_ATT:N-ADJ----------------+          +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                                            |    
      +------------MOD_ATT:N-ADJ------------+              |          |                    +------------------------------COMP:N-N(of)------------------------------+                                                                            |    
      |      +---------MOD_ATT:N-ADJ--------+              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           +-------------------------OBJ:V-N------------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           |              +-----------------SUBJ:V-N----------------+                   |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,mRNA)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 56

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                                   
                                  |         |              +-------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------+                                                   
                                  |         |              |          +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |              |          +------------------------------------------------COMP:N-N(of)------------------------------------------------+              |                                                   
                                  |         |              |          |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+              |                                                   
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(In) (increase,__NODE__)
COMP:V-N(In) (increase,deferoxamine)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 57

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+                                                  |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 58

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                                   
                                  |         |              +-------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------+                                                   
                                  |         |              |          +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |              |          |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(In) (increase,__NODE__)
COMP:V-N(In) (increase,deferoxamine)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 59

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+                                                   
                                  |         |                         +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |                         +------------------------------------------------COMP:N-N(of)------------------------------------------------+              |                                                   
                                  |         |                         |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |                         |                    +--------------------------------------COMP:N-N(of)-------------------------------------+              |                                                   
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 60

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   +---------------------OBJ:V-N--------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +-----------------SUBJ:V-N----------------+                   |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      |              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD:V_PASS-ADV (increase,by)
OBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mRNA)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 61

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   +-------OBJ:V-N-------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 62

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
      +--------------------MOD_ATT:N-ADJ-------------------+---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
      |      +----------------MOD_ATT:N-ADJ----------------+          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
      +------------MOD_ATT:N-ADJ------------+              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
      |      +---------MOD_ATT:N-ADJ--------+              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   +-------OBJ:V-N-------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 63

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
      +--------------------MOD_ATT:N-ADJ-------------------+---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
      |      +----------------MOD_ATT:N-ADJ----------------+          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
      +------------MOD_ATT:N-ADJ------------+              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
      |      +---------MOD_ATT:N-ADJ--------+              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-----------------OBJ:V-N-----------------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+                          +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 64

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
      +--------------------MOD_ATT:N-ADJ-------------------+          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
      |      +----------------MOD_ATT:N-ADJ----------------+          +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                        |                        
      +------------MOD_ATT:N-ADJ------------+              |          |                    +------------------------------COMP:N-N(of)------------------------------+                                                        |                        
      |      +---------MOD_ATT:N-ADJ--------+              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |                                                        |                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 65

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+                                                                                                       
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +-----------------OBJ:V-N-----------------+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 66

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |                          +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 67

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                    |                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 68

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------+                        
                                  |         |                         |            +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                        
                                  |         |                         |            |       +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |            |       |             +-----------------MOD_ATT:N-ADJ----------------+                                                                    |                        
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,mesylate)
COMP:V-N(In) (induce,__NODE__)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 69

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 70

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------+                        
                                  |         |                         |            +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                        
                                  |         |                         |            |       +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |            |       |                                     +------------------------------------------SUBJ:V-N-----------------------------------------+                        
                                  |         |                         |            |       |                                     +-----------------------------OBJ:V-N----------------------------+                          |                        
                                  |         |                         |            |       |                                     |                      +-----------------SUBJ:V-N----------------+                          |                        
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       |                                     |                      +-------COMP:N-N(of)-------+              |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+                      |           +-MOD_ATT:N-ADJ+              |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,dihydrochloride)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,mesylate)
COMP:V-N(In) (induce,__NODE__)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,dihydrochloride)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 71

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------+                        
      +--------------------------------MOD_ATT:N-ADJ-------------------------------+---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                        
      |      +----------------------------MOD_ATT:N-ADJ----------------------------+       +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
      +-------------------------MOD_ATT:N-ADJ-------------------------+            |       |                                     +------------------------------------------SUBJ:V-N-----------------------------------------+                        
      |      +----------------------MOD_ATT:N-ADJ---------------------+            |       |                                     +-----------------------------OBJ:V-N----------------------------+                          |                        
      +------------MOD_ATT:N-ADJ------------+                         |            |       |                                     |                      +-----------------SUBJ:V-N----------------+                          |                        
      |      +---------MOD_ATT:N-ADJ--------+                         |            |       |                                     |                      +--------------SUBJ:V-N-------------+     |                          |                        
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       |                                     |                      +-------COMP:N-N(of)-------+        |     |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+                      |           +-MOD_ATT:N-ADJ+        |     |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+            +MOD_ATT:N+           |       +MOD_AT+        |     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (mesylate,major)
MOD_ATT:N-ADJ (mesylate,pelvic)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,dihydrochloride)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,mesylate)
COMP:V-N(In) (induce,__NODE__)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,dihydrochloride)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 72

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |                          +---SUBJ:V-N---+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 73

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+                     +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 74

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                             +-------OBJ:V-N-------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 75

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 76

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          +------------------------------------------------COMP:N-N(of)------------------------------------------------+                                         |                        
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+                                         |                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                         |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+                                         |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 77

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 78

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+                                                  |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 79

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 80

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
      +--------------------------------MOD_ATT:N-ADJ-------------------------------+                                                          |                                                                                                       
      |      +----------------------------MOD_ATT:N-ADJ----------------------------+                                                          |                                                                                                       
      +-------------------------MOD_ATT:N-ADJ-------------------------+            |                                                          |                                                                                                       
      |      +----------------------MOD_ATT:N-ADJ---------------------+            |                                                          |                                                                                                       
      +------------MOD_ATT:N-ADJ------------+                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
      |      +---------MOD_ATT:N-ADJ--------+                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       +---------------------SUBJ:V-N---------------------+                                                                                                       
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         +-----------------OBJ:V-N-----------------+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (mesylate,major)
MOD_ATT:N-ADJ (mesylate,pelvic)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 81

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 82

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                                                                                                       
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +-----------------OBJ:V-N-----------------+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 83

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+                     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 84

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 85

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                        |                        
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+                                                        |                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |                                                        |                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 86

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                                                                                                       
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 87

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+                     +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 88

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 89

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 90

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   +-------OBJ:V-N-------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 91

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+                     +-----------OBJ:V-N-----------+                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 92

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |                          +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 93

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 94

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 95

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 96

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 97

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                         |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+                                         |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 98

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                |                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   +-------OBJ:V-N-------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 99

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------+                        
                                  |         |                         |            +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                        
                                  |         |                         |            |       +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |            |       +----------------------------------COMP:N-N(of)----------------------------------+                                                |                        
                                  |         |                         |            |       |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                |                        
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,mesylate)
COMP:V-N(In) (induce,__NODE__)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 100

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+                     +-----------OBJ:V-N-----------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     |              +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 101

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          +------------------------------------------------COMP:N-N(of)------------------------------------------------+                                         |                        
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+                                         |                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                         |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+                                         |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD:V_PASS-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 102

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-----------------OBJ:V-N-----------------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+                     |                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 103

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-----------------OBJ:V-N-----------------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 104

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                             +-------OBJ:V-N-------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 105

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +-----------------OBJ:V-N-----------------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 106

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   +-------OBJ:V-N-------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 107

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                                        |    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 108

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                                        |    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 109

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------+                        
                                  |         |                         |            +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                        
                                  |         |                         |            |       +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |            |       |             +-----------------MOD_ATT:N-ADJ----------------+                                                                    |                        
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,mesylate)
COMP:V-N(In) (induce,__NODE__)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 110

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                |                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                |                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 111

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                                    |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                    |    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 112

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 113

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+                                                                            |    
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                                            |    
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+                                                                            |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           +-----------OBJ:V-N-----------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 114

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                                    |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                    |    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 115

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
      +--------------------MOD_ATT:N-ADJ-------------------+                                                                                  |                                                                                                       
      |      +----------------MOD_ATT:N-ADJ----------------+                                                                                  |                                                                                                       
      +------------MOD_ATT:N-ADJ------------+              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
      |      +---------MOD_ATT:N-ADJ--------+              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                             +-------OBJ:V-N-------+                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 116

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          +---------------------------------------------COMP:N-N(of)--------------------------------------------+                                                |                        
                                  |         |              |          |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                |                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   +-------OBJ:V-N-------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 117

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-----------------OBJ:V-N-----------------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+                          +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 118

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-----------------OBJ:V-N-----------------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 119

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |                         +-------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------+    
                                  |         |                         |            +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+    
                                  |         |                         |            |       +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |            |       |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       |             |          +------------MOD_ATT:N-N------------+           +-----------OBJ:V-N-----------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          |            +------MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,mesylate)
COMP:V-N(In) (__SP__,__NODE__)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 120

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    +--------------------------------------COMP:N-N(of)-------------------------------------+                                                             |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+                                                             |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 121

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +-----------------OBJ:V-N-----------------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 122

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+                     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 123

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+                                                        |                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           +-----------OBJ:V-N-----------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 124

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                    |                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 125

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |                                     +------------------------------------------SUBJ:V-N-----------------------------------------+                        
                                  |         |                         |                    |                                     +-----------------------------OBJ:V-N----------------------------+                          |                        
                                  |         |                         |                    |                                     |                      +-----------------SUBJ:V-N----------------+                          |                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |                                     |                      +-------COMP:N-N(of)-------+              |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+                      |           +-MOD_ATT:N-ADJ+              |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,dihydrochloride)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,dihydrochloride)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 126

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                                            |    
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+                                                                            |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           +-----------OBJ:V-N-----------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 127

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+                                                                                                       
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 128

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |                                     +------------------------------------------SUBJ:V-N-----------------------------------------+                        
                                  |         |                         |                    |                                     +-----------------------------OBJ:V-N----------------------------+                          |                        
                                  |         |                         |                    |                                     |                      +-----------------SUBJ:V-N----------------+                          |                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |                                     |                      +-------COMP:N-N(of)-------+              |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+                      |           +-MOD_ATT:N-ADJ+              |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+            +MOD_ATT:N+           |       +MOD_AT+SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,dihydrochloride)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,dihydrochloride)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 129

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+                                                                            |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |                                                                            |    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 130

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                    |                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 131

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                                        |    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 132

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-----------------OBJ:V-N-----------------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 133

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                    |                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+-----------------OBJ:V-N-----------------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 134

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |                                     +------------------------------------------SUBJ:V-N-----------------------------------------+                        
                                  |         |                         |                    |                                     +-----------------------------OBJ:V-N----------------------------+                          |                        
                                  |         |                         |                    |                                     |                      +-----------------SUBJ:V-N----------------+                          |                        
                                  |         |                         |                    |                                     |                      +--------------SUBJ:V-N-------------+     |                          |                        
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |                                     |                      +-------COMP:N-N(of)-------+        |     |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+                      |           +-MOD_ATT:N-ADJ+        |     |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+            +MOD_ATT:N+           |       +MOD_AT+        |     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,dihydrochloride)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,dihydrochloride)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 135

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 136

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                                   
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 137

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         |           +-----------OBJ:V-N-----------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           |              +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 138

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+                                                   
                                  |         |                         +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |                         |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 139

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
      +--------------------MOD_ATT:N-ADJ-------------------+--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
      |      +----------------MOD_ATT:N-ADJ----------------+          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
      +------------MOD_ATT:N-ADJ------------+              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
      |      +---------MOD_ATT:N-ADJ--------+              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 140

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                                   
                                  |         |              +-------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------+                                                   
                                  |         |              |          +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |              |          +------------------------------------------------COMP:N-N(of)------------------------------------------------+              |                                                   
                                  |         |              |          |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+              |                                                   
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(In) (increase,__NODE__)
COMP:V-N(In) (increase,deferoxamine)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 141

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
      +--------------------MOD_ATT:N-ADJ-------------------+                                                                                  |                                                                                                       
      |      +----------------MOD_ATT:N-ADJ----------------+                                                                                  |                                                                                                       
      +------------MOD_ATT:N-ADJ------------+              +-----------------------------------COMP:V-N(In)-----------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                                   
      |      +---------MOD_ATT:N-ADJ--------+              |          +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V-N-------------+     |                                                   
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+        |     |                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+        |     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+        |     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 142

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                                   
                                  |         |              +-------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------+                                                   
                                  |         |              |          +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |              |          |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(In) (increase,__NODE__)
COMP:V-N(In) (increase,deferoxamine)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 143

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                                   
                                  |         |              +-------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------+                                                   
                                  |         |              |          +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |              |          |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |              |          |                    |                                                            +-----------------SUBJ:V-N----------------+                                                   
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+--------------SUBJ:V-N-------------+     |                                                   
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+        |     |                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+        |     +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+        |     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(In) (increase,__NODE__)
COMP:V-N(In) (increase,deferoxamine)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 144

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      |              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 145

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
      +--------------------MOD_ATT:N-ADJ-------------------+                                                                                  |                                                                                                       
      |      +----------------MOD_ATT:N-ADJ----------------+                                                                                  |                                                                                                       
      +------------MOD_ATT:N-ADJ------------+              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
      |      +---------MOD_ATT:N-ADJ--------+              |          +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         |                   +-------OBJ:V-N-------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 146

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      |              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 147

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 148

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 149

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 150

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 151

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 152

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 153

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V-N-------------+     |                                   |               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+        |     |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+        |     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+        |     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 154

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 155

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-----------OBJ:V-N-----------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 156

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                                   
                                  |         |              +-------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------+                                                   
                                  |         |              |          +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |              |          |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+              |                                                   
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(In) (increase,__NODE__)
COMP:V-N(In) (increase,deferoxamine)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 157

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 158

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+                                                                            |    
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                                            |    
                                  |         |                         |                    |                                                            +----------------------------------------SUBJ:V-N----------------------------------------+    
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+-------------------------OBJ:V-N------------------------+                   |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       +--------------------SUBJ:V-N--------------------+                   |    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       +-------OBJ:V-N-------+                          |                   |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |       |      +---SUBJ:V-N---+                          |                   |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       |      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 159

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 160

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         |           +-----------OBJ:V-N-----------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           |              +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 161

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 162

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                                   
                                  |         |              +-------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------+                                                   
                                  |         |              |          +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |              |          +------------------------------------------------COMP:N-N(of)------------------------------------------------+              |                                                   
                                  |         |              |          |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |              |          |                    +--------------------------------------COMP:N-N(of)-------------------------------------+              |                                                   
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,mRNA)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,mRNA)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(In) (increase,__NODE__)
COMP:V-N(In) (increase,deferoxamine)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 163

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |                         +---------------------------------------------COMP:V-N(In)--------------------------------------------+                                                                         
                                  |         |                         |            +--------------------------------------COMP:V-N(In)--------------------------------------+                                                                         
                                  |         |                         |            |       +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |            |       +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |            |       |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      |              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,mesylate)
COMP:V-N(In) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 164

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      |              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 165

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 166

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                                            |    
                                  |         |              |          |                    |                                                            +----------------------------------------SUBJ:V-N----------------------------------------+    
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+                                                                            |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           +-------------------------OBJ:V-N------------------------+                   |    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       +--------------------SUBJ:V-N--------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           |       +-------OBJ:V-N-------+                          |                   |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       |      +---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 167

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 168

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+         +--------------SUBJ:V_PASS-N--------------+                                                   
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 169

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
      +--------------------------------MOD_ATT:N-ADJ-------------------------------+                                                          |                                                                                                       
      |      +----------------------------MOD_ATT:N-ADJ----------------------------+                                                          |                                                                                                       
      +-------------------------MOD_ATT:N-ADJ-------------------------+            |                                                          |                                                                                                       
      |      +----------------------MOD_ATT:N-ADJ---------------------+            |                                                          |                                                                                                       
      +------------MOD_ATT:N-ADJ------------+                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
      |      +---------MOD_ATT:N-ADJ--------+                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (mesylate,major)
MOD_ATT:N-ADJ (mesylate,pelvic)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 170

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+                                                  |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 171

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                                   
                                  |         |                         +--------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                                   
                                  |         |                         |            +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
                                  |         |                         |            |       +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |                         |            |       |             +-----------------MOD_ATT:N-ADJ----------------+-----------------SUBJ:V-N----------------+                                                   
      +--------MOD_ATT:N-N--------+         |                         |            |       |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+              +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            |            +MOD_ATT:N+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(In) (increase,__NODE__)
COMP:V-N(In) (increase,mesylate)
COMP:V-N(In) (increase,__NODE__)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 172

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 173

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 174

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       +-----------------------COMP:V-N(by)----------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 175

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    |                                                            +----------------------------------------SUBJ:V-N----------------------------------------+    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           +-------------------------OBJ:V-N------------------------+                   |    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       +--------------------SUBJ:V-N--------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           |       +-------OBJ:V-N-------+                          |                   |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       |      +---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 176

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         |                   +-------OBJ:V-N-------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 177

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 178

                                  +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                   
                                  |         +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+                                                   
                                  |         |                         +----------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                   
                                  |         |                         |                    +-----------------------------------------------SUBJ:V-N-----------------------------------------------+                                                   
                                  |         |                         |                    |                                                            +-----------------SUBJ:V-N----------------+                                                   
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+--------------SUBJ:V-N-------------+     |                                                   
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+-------COMP:N-N(of)-------+        |     |                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-MOD_ATT:N-ADJ+        |     +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           |       +MOD_AT+        |     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mesylate)
SUBJ:V-N (increase,protein)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 179

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |                         +-------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------+    
                                  |         |                         |            +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+    
                                  |         |                         |            |       +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |            |       |                                                            +----------------------------------------SUBJ:V-N----------------------------------------+    
                                  |         |                         |            |       |             +-----------------MOD_ATT:N-ADJ----------------+           +-------------------------OBJ:V-N------------------------+                   |    
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       |             |          +------------MOD_ATT:N-N------------+           |       +--------------------SUBJ:V-N--------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          |            +------MOD_ATT:N-N-----+           |       +-------OBJ:V-N-------+                          |                   |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            |            +MOD_ATT:N+COMP:N-N(of+       |      +---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,mesylate)
COMP:V-N(In) (__SP__,__NODE__)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 180

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 181

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------COMP:N-N(of)--------------------------------------------+                                                                    |    
                                  |         |                         |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                                    |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   +---------------------OBJ:V-N--------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +-----------------SUBJ:V-N----------------+                   |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      |              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD:V_PASS-ADV (increase,by)
OBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mRNA)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 182

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   +---------------------OBJ:V-N--------------------+                   |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +-----------------SUBJ:V-N----------------+                   |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      |              +MOD:V_+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD:V_PASS-ADV (increase,by)
OBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mRNA)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 183

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                    |                        
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+-----------------OBJ:V-N-----------------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 184

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+                                                                                                       
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 185

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 186

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V-N-------------+     |                                   |               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+        |     |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+        |     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+        |     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 187

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |                                     +------------------------------------------SUBJ:V-N-----------------------------------------+                        
                                  |         |                         |                    |                                     +-----------------------------OBJ:V-N----------------------------+                          |                        
                                  |         |                         |                    |                                     |                      +-----------------SUBJ:V-N----------------+                          |                        
      +--------MOD_ATT:N-N--------+         |                         |                    |                                     |                      +-------COMP:N-N(of)-------+              |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+                      |           +-MOD_ATT:N-ADJ+              |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,dihydrochloride)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,dihydrochloride)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 188

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          |                    |                                                  +-----------------------------------SUBJ:V-N-----------------------------------+                        
                                  |         |              |          |                    |                                                  +----------------------OBJ:V-N----------------------+                          |                        
                                  |         |              |          |                    |                                                  |         +-----------------SUBJ:V-N----------------+                          |                        
      +--------MOD_ATT:N-N--------+         |              |          |                    |             +------------MOD_ATT:N-ADJ-----------+         +-------COMP:N-N(of)-------+              |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          +-------MOD_ATT:N-N-------+         |           +-MOD_ATT:N-ADJ+              |                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            +-MOD_ATT:N-N+         |           |       +MOD_AT+              +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,triethylene)
MOD_ATT:N-N (decrease,tetramine)
MOD_ATT:N-N (decrease,dihydrochloride)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,decrease)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 189

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------+                        
                                  |         |                         |            +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                        
                                  |         |                         |            |       +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |            |       |                                                  +-----------------------------------SUBJ:V-N-----------------------------------+                        
                                  |         |                         |            |       |                                                  +----------------------OBJ:V-N----------------------+                          |                        
                                  |         |                         |            |       |                                                  |         +-----------------SUBJ:V-N----------------+                          |                        
      +--------MOD_ATT:N-N--------+         |                         |            |       |             +------------MOD_ATT:N-ADJ-----------+         +-------COMP:N-N(of)-------+              |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          +-------MOD_ATT:N-N-------+         |           +-MOD_ATT:N-ADJ+              |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            +-MOD_ATT:N-N+         |           |       +MOD_AT+              +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (decrease,triethylene)
MOD_ATT:N-N (decrease,tetramine)
MOD_ATT:N-N (decrease,dihydrochloride)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,mesylate)
COMP:V-N(In) (induce,__NODE__)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,decrease)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 190

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                             +-------OBJ:V-N-------+                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 191

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                             +----------------------------COMP:N-N(of)----------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 192

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |                          +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 193

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 194

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
      +--------------------MOD_ATT:N-ADJ-------------------+--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
      |      +----------------MOD_ATT:N-ADJ----------------+          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
      +------------MOD_ATT:N-ADJ------------+              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
      |      +---------MOD_ATT:N-ADJ--------+              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |      +-------------------------COMP:N-N(of)------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------COMP:N-N(by)-------------------+          |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+                                   |          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 195

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------COMP:N-N(of)--------------------------------------------+                                                                    |    
                                  |         |              |          |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                                    |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                    |    
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 196

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+                                                                                                       
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 197

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+                     +-----------OBJ:V-N-----------+                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |                     |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 198

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+                                                  |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 199

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+                     +------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 200

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 201

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 202

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 203

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 204

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
      +--------------------MOD_ATT:N-ADJ-------------------+                                                                                  |                                                                                                       
      |      +----------------MOD_ATT:N-ADJ----------------+                                                                                  |                                                                                                       
      +------------MOD_ATT:N-ADJ------------+              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
      |      +---------MOD_ATT:N-ADJ--------+              |          +--------------------------------SUBJ:V-N-------------------------------+                     +--------------------------------COMP:N-N(of)--------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                     +-----------OBJ:V-N-----------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |                     |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 205

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 206

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           +-----------OBJ:V-N-----------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 207

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 208

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+                                                                                                       
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 209

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------COMP:N-N(by)-------------------+               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 210

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
      +--------------------MOD_ATT:N-ADJ-------------------+                                                                                  |                                                                                                       
      |      +----------------MOD_ATT:N-ADJ----------------+                                                                                  |                                                                                                       
      +------------MOD_ATT:N-ADJ------------+              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
      |      +---------MOD_ATT:N-ADJ--------+              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (__NODE__,major)
MOD_ATT:N-ADJ (__NODE__,pelvic)
MOD_ATT:N-ADJ (deferoxamine,major)
MOD_ATT:N-ADJ (deferoxamine,pelvic)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 211

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 212

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 213

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 214

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 215

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 216

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 217

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+                     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 218

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                        |                        
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+                                                        |                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           +-----------OBJ:V-N-----------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 219

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+                                                                            |    
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                                            |    
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+                                                                            |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           +-----------OBJ:V-N-----------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 220

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 221

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 222

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 223

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |                                     +------------------------------------------SUBJ:V-N-----------------------------------------+                        
                                  |         |                         |                    |                                     +-----------------------------OBJ:V-N----------------------------+                          |                        
                                  |         |                         |                    |                                     |                      +-----------------SUBJ:V-N----------------+                          |                        
      +--------MOD_ATT:N-N--------+         |                         |                    |                                     |                      +-------COMP:N-N(of)-------+              |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+                      |           +-MOD_ATT:N-ADJ+              |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+            +MOD_ATT:N+           |       +MOD_AT+SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,dihydrochloride)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,dihydrochloride)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 224

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |                                                  +-----------------------------------SUBJ:V-N-----------------------------------+                        
                                  |         |                         |                    |                                                  +----------------------OBJ:V-N----------------------+                          |                        
                                  |         |                         |                    |                                                  |         +-----------------SUBJ:V-N----------------+                          |                        
      +--------MOD_ATT:N-N--------+         |                         |                    |             +------------MOD_ATT:N-ADJ-----------+         +-------COMP:N-N(of)-------+              |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          +-------MOD_ATT:N-N-------+         |           +-MOD_ATT:N-ADJ+              |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            +-MOD_ATT:N-N+         |           |       +MOD_AT+              +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,triethylene)
MOD_ATT:N-N (decrease,tetramine)
MOD_ATT:N-N (decrease,dihydrochloride)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,decrease)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 225

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+                             +----------------------------COMP:N-N(of)----------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 226

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 227

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |                         +---------------------------------------------COMP:V-N(In)--------------------------------------------+                                                                         
                                  |         |                         |            +--------------------------------------COMP:V-N(In)--------------------------------------+                                                                         
                                  |         |                         |            |       +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |            |       |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,mesylate)
COMP:V-N(In) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 228

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 229

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |                                                  +-----------------------------------SUBJ:V-N-----------------------------------+                        
                                  |         |                         |                    |                                                  +----------------------OBJ:V-N----------------------+                          |                        
                                  |         |                         |                    |                                                  |         +-----------------SUBJ:V-N----------------+                          |                        
                                  |         |                         |                    |                                                  |         +--------------SUBJ:V-N-------------+     |                          |                        
      +--------MOD_ATT:N-N--------+         |                         |                    |             +------------MOD_ATT:N-ADJ-----------+         +-------COMP:N-N(of)-------+        |     |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          +-------MOD_ATT:N-N-------+         |           +-MOD_ATT:N-ADJ+        |     |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            +-MOD_ATT:N-N+         |           |       +MOD_AT+        |     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,triethylene)
MOD_ATT:N-N (decrease,tetramine)
MOD_ATT:N-N (decrease,dihydrochloride)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,decrease)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 230

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+                                                        |                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |                                                        |                        
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 231

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                        |                        
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+                                                        |                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |                                                        |                        
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 232

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 233

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------COMP:N-N(by)-------------------+          |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+                                   |          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 234

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------COMP:N-N(of)--------------------------------------------+                                                                    |    
                                  |         |              |          |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                                    |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   +-------OBJ:V-N-------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 235

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------COMP:N-N(of)--------------------------------------------+                                                                    |    
                                  |         |              |          |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                                    |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                    |    
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 236

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+                             +----------------------------COMP:N-N(of)----------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 237

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 238

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 239

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                    |                        
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 240

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------COMP:N-N(by)-------------------+          |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+                                   |          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 241

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          |                    |                                     +------------------------------------------SUBJ:V-N-----------------------------------------+                        
                                  |         |              |          |                    |                                     +-----------------------------OBJ:V-N----------------------------+                          |                        
                                  |         |              |          |                    |                                     |                      +-----------------SUBJ:V-N----------------+                          |                        
                                  |         |              |          |                    |                                     |                      +--------------SUBJ:V-N-------------+     |                          |                        
      +--------MOD_ATT:N-N--------+         |              |          |                    |                                     |                      +-------COMP:N-N(of)-------+        |     |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+                      |           +-MOD_ATT:N-ADJ+        |     |                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+            +MOD_ATT:N+           |       +MOD_AT+        |     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,dihydrochloride)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,dihydrochloride)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 242

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |                          +---SUBJ:V-N---+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 243

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                                   
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 244

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       +---------------------SUBJ:V-N---------------------+                             +----------------------------COMP:N-N(of)----------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 245

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+                     +-----------OBJ:V-N-----------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |                     |              +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 246

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                     +--------------------------------COMP:N-N(of)--------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                     +-----------OBJ:V-N-----------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |                     |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 247

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 248

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 249

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                                        |    
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 250

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           +-----------OBJ:V-N-----------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 251

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------+                        
                                  |         |                         |            +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                        
                                  |         |                         |            |       +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |            |       |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +--------MOD_ATT:N-N--------+         |                         |            |       |             |          +------------MOD_ATT:N-N------------+           +-----------OBJ:V-N-----------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          |            +------MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,mesylate)
COMP:V-N(In) (induce,__NODE__)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 252

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------+                        
                                  |         |                         |            +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                        
                                  |         |                         |            |       +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |            |       |                                     +------------------------------------------SUBJ:V-N-----------------------------------------+                        
                                  |         |                         |            |       |                                     +-----------------------------OBJ:V-N----------------------------+                          |                        
                                  |         |                         |            |       |                                     |                      +-----------------SUBJ:V-N----------------+                          |                        
      +--------MOD_ATT:N-N--------+         |                         |            |       |                                     |                      +-------COMP:N-N(of)-------+              |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+                      |           +-MOD_ATT:N-ADJ+              |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+            +MOD_ATT:N+           |       +MOD_AT+SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,dihydrochloride)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,mesylate)
COMP:V-N(In) (induce,__NODE__)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,dihydrochloride)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 253

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------+                        
                                  |         |                         |            +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                        
                                  |         |                         |            |       +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |            |       |                                                  +-----------------------------------SUBJ:V-N-----------------------------------+                        
                                  |         |                         |            |       |                                                  +----------------------OBJ:V-N----------------------+                          |                        
                                  |         |                         |            |       |                                                  |         +-----------------SUBJ:V-N----------------+                          |                        
      +--------MOD_ATT:N-N--------+         |                         |            |       |             +------------MOD_ATT:N-ADJ-----------+         +-------COMP:N-N(of)-------+              |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          +-------MOD_ATT:N-N-------+         |           +-MOD_ATT:N-ADJ+              |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            +-MOD_ATT:N-N+         |           |       +MOD_AT+SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (decrease,triethylene)
MOD_ATT:N-N (decrease,tetramine)
MOD_ATT:N-N (decrease,dihydrochloride)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,mesylate)
COMP:V-N(In) (induce,__NODE__)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,decrease)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 254

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+                                                                            |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |                                                                            |    
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 255

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------+                        
                                  |         |                         |            +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                        
                                  |         |                         |            |       +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |            |       |                                                  +-----------------------------------SUBJ:V-N-----------------------------------+                        
                                  |         |                         |            |       |                                                  +----------------------OBJ:V-N----------------------+                          |                        
                                  |         |                         |            |       |                                                  |         +-----------------SUBJ:V-N----------------+                          |                        
                                  |         |                         |            |       |                                                  |         +--------------SUBJ:V-N-------------+     |                          |                        
      +--------MOD_ATT:N-N--------+         |                         |            |       |             +------------MOD_ATT:N-ADJ-----------+         +-------COMP:N-N(of)-------+        |     |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          +-------MOD_ATT:N-N-------+         |           +-MOD_ATT:N-ADJ+        |     |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            +-MOD_ATT:N-N+         |           |       +MOD_AT+        |     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (decrease,triethylene)
MOD_ATT:N-N (decrease,tetramine)
MOD_ATT:N-N (decrease,dihydrochloride)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,mesylate)
COMP:V-N(In) (induce,__NODE__)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,decrease)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 256

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 257

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 258

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------COMP:N-N(of)--------------------------------------------+                                                |                        
                                  |         |                         |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                |                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   +-------OBJ:V-N-------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 259

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                                    |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   +-------OBJ:V-N-------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 260

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 261

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 262

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V-N-------------+     |                                   |               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+        |     |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+        |     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+        |     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 263

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          +---------------------------------------------COMP:N-N(of)--------------------------------------------+                                                |                        
                                  |         |              |          |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                |                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                |                        
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 264

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------COMP:N-N(of)--------------------------------------------+                                                                    |    
                                  |         |              |          |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                                    |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   +-------OBJ:V-N-------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+      +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 265

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          |                    |                                     +------------------------------------------SUBJ:V-N-----------------------------------------+                        
                                  |         |              |          |                    |                                     +-----------------------------OBJ:V-N----------------------------+                          |                        
                                  |         |              |          |                    |                                     |                      +-----------------SUBJ:V-N----------------+                          |                        
                                  |         |              |          |                    |                                     |                      +--------------SUBJ:V-N-------------+     |                          |                        
      +--------MOD_ATT:N-N--------+         |              |          |                    |                                     |                      +-------COMP:N-N(of)-------+        |     |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+                      |           +-MOD_ATT:N-ADJ+        |     |                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+            +MOD_ATT:N+           |       +MOD_AT+        |     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,dihydrochloride)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,dihydrochloride)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 266

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 267

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                                                                                                       
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 268

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                                                                                                       
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 269

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 270

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 271

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         +---------------------------------------------COMP:N-N(of)--------------------------------------------+                                                |                        
                                  |         |                         |                    +----------------------------------COMP:N-N(of)----------------------------------+                                                |                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                |                        
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 272

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                    |                        
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 273

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+------------------------------SUBJ:V-N------------------------------+                        
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           +-----------OBJ:V-N-----------+                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 274

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 275

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +-------MOD_ATT:N-ADJ-------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------COMP:N-N(by)-------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 276

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                    |                        
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 277

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                    |                        
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+-----------------OBJ:V-N-----------------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 278

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +------------------------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------------------------+                        
                                  |         |                         +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |                         |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |                         |                    |                                     +------------------------------------------SUBJ:V-N-----------------------------------------+                        
                                  |         |                         |                    |                                     +-----------------------------OBJ:V-N----------------------------+                          |                        
                                  |         |                         |                    |                                     |                      +-----------------SUBJ:V-N----------------+                          |                        
      +--------MOD_ATT:N-N--------+         |                         |                    |                                     |                      +-------COMP:N-N(of)-------+              |                          |                        
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+                      |           +-MOD_ATT:N-ADJ+              |                          |                        
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+            +MOD_ATT:N+           |       +MOD_AT+              +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,dihydrochloride)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,dihydrochloride)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 279

                                  +---------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------+                        
                                  |         +----------------------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------------------+                        
                                  |         |              +---------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------+                        
                                  |         |              |          +-----------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------+                        
                                  |         |              |          |                    +-------------------------------------------------------------SUBJ:V-N------------------------------------------------------------+                        
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                    |                        
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+------------------------------SUBJ:V-N------------------------------+                        
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+-----------------OBJ:V-N-----------------+                          |                        
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |      |        |          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
COMP:V-N(In) (induce,__SP__)
COMP:V-N(In) (induce,__NODE__)
COMP:V-N(In) (induce,deferoxamine)
SUBJ:V-N (induce,mesylate)
SUBJ:V-N (induce,protein)
SUBJ:V-N (induce,expression)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
COMP:N-N(of) (diabetes,__SP__)

Analyse 280

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           +-----------OBJ:V-N-----------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 281

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           +-----------OBJ:V-N-----------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 282

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                                        |    
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 283

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                                                                                        |    
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 284

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+                                                                            |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |                                                                            |    
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+----------------------------------------SUBJ:V-N----------------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 285

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 286

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 287

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 288

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                             +-----------------------COMP:N-N(by)----------------------+               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+                             +-------OBJ:V-N-------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,diabetes)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 289

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 290

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 291

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    |                                                            +----------------------------------------SUBJ:V-N----------------------------------------+    
                                  |         |                         |                    |                                                            |           +-------------------------OBJ:V-N------------------------+                   |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       +--------------------SUBJ:V-N--------------------+                   |    
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       +-------OBJ:V-N-------+                          |                   |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |       |      +---SUBJ:V-N---+                          |                   |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       |      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 292

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                             +----------------------------COMP:N-N(of)----------------------------+    
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                             +-----------------------COMP:N-N(by)----------------------+          |    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+                             +-------OBJ:V-N-------+                                   |          |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,diabetes)
COMP:N-N(of) (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 293

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 294

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   +-----------------------COMP:V-N(by)----------------------+               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 295

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 296

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                     +--------------------------------COMP:N-N(of)--------------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                     +---------------------------COMP:N-N(by)--------------------------+          |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+                                   |          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,diabetes)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 297

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                     +---------------------------COMP:N-N(by)--------------------------+               
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+                     +-----------OBJ:V-N-----------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     |              +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 298

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 299

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-----------OBJ:V-N-----------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 300

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   +-----------------------COMP:V-N(by)----------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 301

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 302

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 303

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |                         +---------------------------------------------COMP:V-N(In)--------------------------------------------+                                                                         
                                  |         |                         |            +--------------------------------------COMP:V-N(In)--------------------------------------+                                                                         
                                  |         |                         |            |       +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |            |       |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |            |       |             |          +------------MOD_ATT:N-N------------+                   |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,mesylate)
COMP:V-N(In) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 304

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      |              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 305

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 306

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V-N-------------+     |                                   |               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+        |     |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+        |     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+        |     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 307

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +--------------------------------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------------------------------+    
                                  |         |              +-------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------+    
                                  |         |              |          +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |              |          |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                                            |    
                                  |         |              |          |                    |                                                            +----------------------------------------SUBJ:V-N----------------------------------------+    
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+-------------------------OBJ:V-N------------------------+                   |    
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       +--------------------SUBJ:V-N--------------------+                   |    
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       +-------OBJ:V-N-------+                          |                   |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+           |       |      +---SUBJ:V-N---+                          |                   |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       |      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
COMP:V-N(In) (__SP__,__NODE__)
COMP:V-N(In) (__SP__,deferoxamine)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 308

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                             +----------------------------COMP:N-N(of)----------------------------+    
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+                             +-----------------------COMP:N-N(by)----------------------+          |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+                                   |          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,diabetes)
COMP:N-N(of) (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 309

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       +-----------------------COMP:V-N(by)----------------------+               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 310

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 311

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                             +-----------------------COMP:N-N(by)----------------------+               
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                             +-------OBJ:V-N-------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,diabetes)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 312

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         |                   +-------OBJ:V-N-------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 313

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |                    +---------------------SUBJ:V-N---------------------+                     +---------------------------COMP:N-N(by)--------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 314

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+                                                  |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 315

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         |           +-----------OBJ:V-N-----------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           |              +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 316

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+         +--------------SUBJ:V_PASS-N--------------+                                                   
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+              |                                                   
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+              |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 317

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +-------MOD_ATT:N-ADJ-------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         +-----------------OBJ:V-N-----------------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 318

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V-N-------------+     |                                   |               
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+        |     |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+        |     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+        |     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 319

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+--------------------------------------COMP:V-N(by)-------------------------------------+               
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+         +--------------SUBJ:V-N-------------+     |                                   |               
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+        |     |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+        |     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+        |     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,diabetes)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 320

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+-----------------------COMP:V-N(by)----------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(by) (__NODE__,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 321

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+                     +---------COMP:V_PASS-N(by)---------+               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 322

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |              +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                         
                                  |         |              |          +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |              |          |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |              |          |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |              |          |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,deferoxamine)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 323

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+              +---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 324

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+---------COMP:V_PASS-N(by)---------+          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
COMP:V_PASS-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 325

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                             +----------------------------COMP:N-N(of)----------------------------+    
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                             +-----------------------COMP:N-N(by)----------------------+          |    
      +-------MOD_ATT:N-ADJ-------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                             +-------OBJ:V-N-------+                                   |          |    
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |          |    
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-ADJ (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,diabetes)
COMP:N-N(of) (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 326

                                  +-------------------------------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------------------------------+    
                                  |         +----------------------------------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------------------------------+    
                                  |         |                         +---------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+    
                                  |         |                         |                    +-----------------------------------------------------------------------SUBJ:V-N----------------------------------------------------------------------+    
                                  |         |                         |                    |                                                            +----------------------------------------SUBJ:V-N----------------------------------------+    
                                  |         |                         |                    |                                                            |           +-------------------------OBJ:V-N------------------------+                   |    
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       +--------------------SUBJ:V-N--------------------+                   |    
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       +-------OBJ:V-N-------+                          |                   |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+           |       |      +---SUBJ:V-N---+                          |                   |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       |      +SUBJ:V-N+     +MOD:V-+        +-MOD:V-ADV+-OBJ:V-N+MOD_P+    |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |      |        |          |        |     |    |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD:V-ADV (increase,by)
OBJ:V-N (induce,__SP__)
SUBJ:V-N (induce,__NODE__)
MOD:V-ADV (induce,experimentally)
OBJ:V-N (induce,diabetes)
MOD_POST:N-ADJ (diabetes,of)
COMP:V-N(In) (__SP__,__SP__)
SUBJ:V-N (__SP__,__NODE__)
SUBJ:V-N (__SP__,mesylate)
SUBJ:V-N (__SP__,protein)
SUBJ:V-N (__SP__,expression)

Analyse 327

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 328

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+                     +--------------------------------COMP:N-N(of)--------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 329

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 330

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 331

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+                     +--------------------------------COMP:N-N(of)--------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 332

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 333

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+                     +--------------------------------COMP:N-N(of)--------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 334

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 335

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+                     +--------------------------------COMP:N-N(of)--------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 336

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------COMP:N-N(by)-------------------+               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 337

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |                                                                         
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 338

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 339

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+                   |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+                   |      +-------------------COMP:N-N(by)-------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 340

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+         +--------------SUBJ:V_PASS-N--------------+                                   |               
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +--------------SUBJ:V-N-------------+     |                                   |               
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+        |     |                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+        |     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+        |     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 341

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                    +-------------------------COMP:N-N(of)------------------------+    
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+-------------------COMP:N-N(by)-------------------+          |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+                                   |          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 342

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+                     +--------------------------------COMP:N-N(of)--------------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 343

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------+                                                                         
                                  |         +------------------------------------------------------COMP:N-N(of)-----------------------------------------------------+       |                                                                         
                                  |         |                         +-----------------------------------------------SUBJ:V-N----------------------------------------------+                                                                         
                                  |         |                         +-----------------------------------------COMP:N-N(of)----------------------------------------+       |                                                                         
                                  |         |                         |                    +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |                    +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |                    |             +-----------------MOD_ATT:N-ADJ----------------+           |       |                                                                         
      +--------MOD_ATT:N-N--------+         |                         |                    |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------COMP:N-N(by)-------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
COMP:N-N(of) (__NODE__,__SP__)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (mesylate,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,mesylate)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 344

                                  +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                         
                                  |         +----------------------------------------------------------COMP:V-N(In)---------------------------------------------------------+                                                                         
                                  |         |                         +---------------------------------------------COMP:V-N(In)--------------------------------------------+                                                                         
                                  |         |                         |            +--------------------------------------COMP:V-N(In)--------------------------------------+                                                                         
                                  |         |                         |            |       +------------------------------------SUBJ:V-N------------------------------------+                                                                         
                                  |         |                         |            |       +------------------------------COMP:N-N(of)------------------------------+       |                                                                         
                                  |         |                         |            |       |             +-----------------MOD_ATT:N-ADJ----------------+           |       |      +-------------------------COMP:N-N(of)------------------------+    
      +--------MOD_ATT:N-N--------+         |                         |            |       |             |          +------------MOD_ATT:N-N------------+           |       |      +-------------------COMP:N-N(by)-------------------+          |    
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             |          |            +------MOD_ATT:N-N-----+------SUBJ:V-N-----+      +-SUBJ:V_PASS-N+                                   |          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          |            |            +MOD_ATT:N+COMP:N-N(of+       +OBJ:V-+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
COMP:N-N(of) (protein,__SP__)
MOD_ATT:N-ADJ (expression,triethylene)
MOD_ATT:N-N (expression,tetramine)
MOD_ATT:N-N (expression,dihydrochloride)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
COMP:V-N(In) (__NODE__,__NODE__)
COMP:V-N(In) (__NODE__,mesylate)
COMP:V-N(In) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,protein)
SUBJ:V-N (__NODE__,expression)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(by) (mRNA,diabetes)
COMP:N-N(of) (mRNA,__SP__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 345

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 346

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                  |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 347

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-------COMP:N-N(of)-------+                                                                  
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |           +-MOD_ATT:N-ADJ+-------------------COMP:N-N(by)-------------------+               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           |       +MOD_AT+-SUBJ:V_PASS-N+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(by) (mRNA,diabetes)
SUBJ:V_PASS-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 348

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+                             +----------------------------COMP:N-N(of)----------------------------+    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 349

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                     +--------------------------------COMP:N-N(of)--------------------------------+    
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+                     +-----------OBJ:V-N-----------+                                              |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     |              +---SUBJ:V-N---+------------COMP:V-N(by)-----------+          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,diabetes)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 350

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+                             +-----------------------COMP:N-N(by)----------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,diabetes)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 351

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                             +-----------------------COMP:N-N(by)----------------------+               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,diabetes)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 352

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         |                          +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 353

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+                     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 354

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+                     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 355

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +-----------------OBJ:V-N-----------------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 356

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +-----------------OBJ:V-N-----------------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 357

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                             +----------------------------COMP:N-N(of)----------------------------+    
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+                             +-----------------------COMP:N-N(by)----------------------+          |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+                                   |          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,diabetes)
COMP:N-N(of) (__NODE__,__SP__)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 358

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                             +-----------------------COMP:N-N(by)----------------------+               
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+                             +-------OBJ:V-N-------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,diabetes)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 359

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                     +---------------------------COMP:N-N(by)--------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+                     +-----------OBJ:V-N-----------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     |              +---SUBJ:V-N---+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+SUBJ:V-N+     |                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 360

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+                     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 361

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +---------------------------------------------SUBJ:V-N--------------------------------------------+                                                                                                       
                                  |         |                         +--------------------------------SUBJ:V-N-------------------------------+                     +--------------------------------COMP:N-N(of)--------------------------------+    
      +--------MOD_ATT:N-N--------+         |                         |                    +---------------------SUBJ:V-N---------------------+                     +---------------------------COMP:N-N(by)--------------------------+          |    
      |      +----MOD_ATT:N-ADJ---+         |                         |                    |             +-----MOD_ATT:N-ADJ-----+            |                     +-----------OBJ:V-N-----------+                                   |          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,diabetes)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 362

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                                                                                                       
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+                             +-----------------------COMP:N-N(by)----------------------+               
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+-------OBJ:V-N-------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,diabetes)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 363

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+                                                                                                       
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +-----------------OBJ:V-N-----------------+                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+COMP:N-N(of+       +MOD_AT+---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)

Analyse 364

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |                         +------------------------------COMP:V-N(In)-----------------------------+                             +----------------------------COMP:N-N(of)----------------------------+    
                                  |         |                         |            +-----------------------COMP:V-N(In)-----------------------+                             +-----------------------COMP:N-N(by)----------------------+          |    
      +--------MOD_ATT:N-N--------+         |                         |            |       +---------------------SUBJ:V-N---------------------+                             +-------OBJ:V-N-------+                                   |          |    
      |      +----MOD_ATT:N-ADJ---+         |                         |            |       |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+      +---SUBJ:V-N---+                                   |          |    
      |      |       +-MOD_ATT:N-N+         |              +MOD_ATT:N-+            |       |             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +SUBJ:V-N+     |                          +MOD_ATT:+          |    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |        |     |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-N (mesylate,deferoxamine)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,mesylate)
COMP:V-N(In) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,diabetes)
COMP:N-N(of) (__NODE__,__SP__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,__NODE__)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)

Analyse 365

                                  +------------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                                                                       
                                  |         +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                       
                                  |         |              +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                       
                                  |         |              |          +--------------------------------SUBJ:V-N-------------------------------+         +---------------------------------COMP:N-N(by)--------------------------------+               
      +--------MOD_ATT:N-N--------+         |              |          |                    +---------------------SUBJ:V-N---------------------+         +-----------------OBJ:V-N-----------------+                                   |               
      |      +----MOD_ATT:N-ADJ---+         |              |          |                    |             +-----MOD_ATT:N-ADJ-----+            |         +----COMP:N-N(of)---+                     |                                   |               
      |      |       +-MOD_ATT:N-N+         |              |          |            +MOD_ATT+             |          +-MOD_ATT:N-N+--SUBJ:V-N--+-OBJ:V-N-+           +MOD_ATT+      +---SUBJ:V-N---+                          +MOD_ATT:+COMP:N-N(o+    
      |      |       |            |         |              |          |            |       |             |          |            |            |         |           |       |      |              |                          |        |          |    
 In major pelvic ganglion from __SP__ , __NODE__ and deferoxamine mesylate and __NODE__ protein and triethylene tetramine dihydrochloride decrease expression of __SP__ __NODE__ mRNA that is increased by experimentally induced diabetes of __SP__ .
MOD_ATT:N-N (__SP__,major)
MOD_ATT:N-ADJ (__SP__,pelvic)
MOD_ATT:N-N (__SP__,ganglion)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (dihydrochloride,triethylene)
MOD_ATT:N-N (dihydrochloride,tetramine)
COMP:V-N(In) (decrease,__SP__)
COMP:V-N(In) (decrease,__NODE__)
COMP:V-N(In) (decrease,deferoxamine)
SUBJ:V-N (decrease,mesylate)
SUBJ:V-N (decrease,protein)
SUBJ:V-N (decrease,dihydrochloride)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,diabetes)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,mRNA)
MOD_ATT:N-ADJ (diabetes,induce)
COMP:N-N(of) (diabetes,__SP__)